Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.57
+0.09 (1.06%)
At close: Apr 2, 2026, 4:00 PM EDT
8.51
-0.06 (-0.70%)
After-hours: Apr 2, 2026, 4:10 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $49.21 million as of April 2, 2026. Its market cap has increased by 19.80% in one year.
Market Cap
49.21M
Enterprise Value
-81.37M
1-Year Change
19.80%
Ranking
Category
Stock Price
$8.57
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $49.21M, a decrease of -88.47%. That is a compound annual growth rate of -38.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 49.21M | 46.41% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 53.77M |
| NovaBay Pharmaceuticals | 51.92M |
| Radiopharm Theranostics | 51.41M |
| Edesa Biotech | 51.26M |
| Mereo BioPharma Group | 51.08M |
| Metagenomi Therapeutics | 50.79M |
| MiNK Therapeutics | 50.18M |
| Aligos Therapeutics | 49.32M |